NL-OMON31961
Not yet recruiting
Not Applicable
Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodes - Tumorresponse monitoring of primary systemic therapy
Antoni van Leeuwenhoek Ziekenhuis0 sites300 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 300
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion in one of the clinical protocols that are part of the NKI\-AVL neoadjuvant therapy program; women with breastcancer \> 3 cm and/or axillary lymph node metastasis
Exclusion Criteria
- •Exclusion in one of the clinical protocols that are part of the NKI\-AVL neoadjuvant therapy program; Pregnancy or breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Onderzoek naar het bepalen van de reactie op chemotherapie van tumorcellen in de borst en in de oksel.breast cancerneoadjuvant chemotherapyaxillary lymph node metastasisFDG-PET/CTIodine-125 seedsNL-OMON21498Philips300
Recruiting
Not Applicable
Tumor response assessment in breast cancer patients receiving neoadjuvant systemic therapy using optical mammography: the Softscan Studybreast cancermammacarcinoma10006291NL-OMON36040eids Universitair Medisch Centrum42
Completed
Not Applicable
Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014Breast CancerNCT01503034Centre Oscar Lambret394
Recruiting
Not Applicable
Observational study on breast cancer detection using autoantibodies against the antigen of cancer stem cellsBreast cancerJPRN-UMIN000045144Sapporo Medical University350
Completed
Not Applicable
on-invasive monitoring of breast cancer therapy using circulating tumor DNA from peripheral bloodNL-OMON43952Erasmus MC, Universitair Medisch Centrum Rotterdam90